Home Bratislava Medical Journal 2019 Bratislava Medical Journal Vol.120, No.6, p.476–480, 2019

Journal info


 


Published Monthly, in English
Founded: 1919
ISSN 0006-9248
(E)ISSN 1336-0345

Impact factor 1.564

 

Aims and Scope
Editorial Info
Submission Guidelines

Select Journal







Webshop Cart

Your Cart is currently empty.

Info: Your browser does not accept cookies. To put products into your cart and purchase them you need to enable cookies.

Bratislava Medical Journal Vol.120, No.6, p.476–480, 2019

Title: Evaluation of neutrophil-to-lymphocyte ratio and hematologic parameters in patients with Graves’ disease
Author: E. Turan

Abstract: AIM: While the ratio of neutrophil-to-lymphocyte (NLR) increases with inflammation, its importance in Graves’ disease is not clear. The aim of this study was to evaluate NLR, a marker of chronic inflammmation, in Graves’ disease.
METHODS: 86 Graves’ patients (37 before treatment,49 euthyroid patients after treatment) and 112 controls were enrolled. Hematologic parameters, thyroid function tests, age and gender were recorded. NLRs were calculated. Firstly, groups were composed as Graves’ group (Group1) and participants without thyroid disorder as control group (Group2). Secondly, Graves’ patients before treatment were considered as Group1a, euthyroid Graves’ patients after antithyroid treatment were considered as Group1b. These groups were compared with each other in terms of descriptive data and hematological parameters.
RESULTS: Lymphocyte, monocyte, platelet, free T3, and free T4 levels were significantly higher in Graves’ group than the controls. TSH and NLR were significantly lower in Graves’ group Graves’ than the controls. Differences among group1a and group1b for monocyte (p = 0.013), for basophil (p= 0.002), for platelet (p = 0.029), and for NLR (p = 0.029) were statistically significant.
CONCLUSION: Unlike other inflammatory diseases, in Graves’ disease; hematological parameters may not give information about inflammatory state of the disease. Therefore, NLR should be evaluated with other serum inflammatory markers in Graves’ disease (Tab. 2, Fig. 1, Ref. 26).

Keywords: Graves’ disease, inflammation, neutrophils, platelet count
Published online: 21-Jun-2019
Year: 2019, Volume: 120, Issue: 6 Page From: 476, Page To: 480
doi:10.4149/BLL_2019_076


download file



© AEPress s.r.o
Copyright notice: For any permission to reproduce, archive or otherwise use the documents in the ELiS, please contact AEP.